Compare ASMB & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASMB | IH |
|---|---|---|
| Founded | 2005 | 1996 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 553.6M | 116.0M |
| IPO Year | 2010 | 2020 |
| Metric | ASMB | IH |
|---|---|---|
| Price | $33.33 | $2.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $43.40 | N/A |
| AVG Volume (30 Days) | ★ 140.2K | 9.3K |
| Earning Date | 11-10-2025 | 12-29-2025 |
| Dividend Yield | N/A | ★ 3.88% |
| EPS Growth | N/A | ★ 5.85 |
| EPS | N/A | ★ 0.29 |
| Revenue | $37,191,000.00 | ★ $119,261,855.00 |
| Revenue This Year | $33.33 | $39.02 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.55 |
| Revenue Growth | ★ 31.30 | N/A |
| 52 Week Low | $7.75 | $1.55 |
| 52 Week High | $39.71 | $3.60 |
| Indicator | ASMB | IH |
|---|---|---|
| Relative Strength Index (RSI) | 46.14 | 35.95 |
| Support Level | $31.51 | $2.15 |
| Resistance Level | $38.99 | $2.40 |
| Average True Range (ATR) | 2.13 | 0.13 |
| MACD | -0.31 | 0.00 |
| Stochastic Oscillator | 22.93 | 14.63 |
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.